Logo image of MGN.OL

MAGNORA ASA (MGN.OL) Stock Fundamental Analysis

Europe - Euronext Oslo - OSL:MGN - NO0010187032 - Common Stock

19.52 NOK
-0.32 (-1.61%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

4

MGN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 19 industry peers in the Independent Power and Renewable Electricity Producers industry. While MGN has a great health rating, its profitability is only average at the moment. MGN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MGN has reported negative net income.
In the past year MGN has reported a negative cash flow from operations.
Of the past 5 years MGN 4 years were profitable.
In multiple years MGN reported negative operating cash flow during the last 5 years.
MGN.OL Yearly Net Income VS EBIT VS OCF VS FCFMGN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

With an excellent Return On Assets value of 127.08%, MGN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
MGN has a better Return On Equity (162.90%) than 100.00% of its industry peers.
Industry RankSector Rank
ROA 127.08%
ROE 162.9%
ROIC N/A
ROA(3y)45.75%
ROA(5y)25.52%
ROE(3y)62.41%
ROE(5y)34.96%
ROIC(3y)N/A
ROIC(5y)N/A
MGN.OL Yearly ROA, ROE, ROICMGN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

MGN has a Profit Margin of 25808.70%. This is amongst the best in the industry. MGN outperforms 100.00% of its industry peers.
MGN's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for MGN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 25808.7%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y250.83%
GM growth 3YN/A
GM growth 5YN/A
MGN.OL Yearly Profit, Operating, Gross MarginsMGN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K 20K 25K

7

2. Health

2.1 Basic Checks

MGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MGN has been reduced compared to 1 year ago.
The number of shares outstanding for MGN has been increased compared to 5 years ago.
Compared to 1 year ago, MGN has a worse debt to assets ratio.
MGN.OL Yearly Shares OutstandingMGN.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MGN.OL Yearly Total Debt VS Total AssetsMGN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MGN has an Altman-Z score of 7.69. This indicates that MGN is financially healthy and has little risk of bankruptcy at the moment.
MGN's Altman-Z score of 7.69 is amongst the best of the industry. MGN outperforms 100.00% of its industry peers.
There is no outstanding debt for MGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.69
ROIC/WACCN/A
WACC8.57%
MGN.OL Yearly LT Debt VS Equity VS FCFMGN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MGN has a Current Ratio of 1.99. This is a normal value and indicates that MGN is financially healthy and should not expect problems in meeting its short term obligations.
MGN has a better Current ratio (1.99) than 68.42% of its industry peers.
A Quick Ratio of 1.99 indicates that MGN should not have too much problems paying its short term obligations.
MGN has a Quick ratio of 1.99. This is in the better half of the industry: MGN outperforms 68.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.99
MGN.OL Yearly Current Assets VS Current LiabilitesMGN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1

3. Growth

3.1 Past

The earnings per share for MGN have decreased strongly by -104.27% in the last year.
The Earnings Per Share has been growing by 87.45% on average over the past years. This is a very strong growth
Looking at the last year, MGN shows a very negative growth in Revenue. The Revenue has decreased by -80.99% in the last year.
MGN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -43.96% yearly.
EPS 1Y (TTM)-104.27%
EPS 3YN/A
EPS 5Y87.45%
EPS Q2Q%-106.44%
Revenue 1Y (TTM)-80.99%
Revenue growth 3Y-46.71%
Revenue growth 5Y-43.96%
Sales Q2Q%-99.81%

3.2 Future

Based on estimates for the next years, MGN will show a decrease in Earnings Per Share. The EPS will decrease by -6.23% on average per year.
The Revenue is expected to decrease by -3.11% on average over the next years.
EPS Next Y-65.77%
EPS Next 2Y-9.51%
EPS Next 3Y-6.23%
EPS Next 5YN/A
Revenue Next Year-31.96%
Revenue Next 2Y1.38%
Revenue Next 3Y-3.11%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MGN.OL Yearly Revenue VS EstimatesMGN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
MGN.OL Yearly EPS VS EstimatesMGN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MGN. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 5.69 indicates a rather cheap valuation of MGN.
Based on the Price/Forward Earnings ratio, MGN is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, MGN is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.69
MGN.OL Price Earnings VS Forward Price EarningsMGN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MGN.OL Per share dataMGN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

MGN's earnings are expected to decrease with -6.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.51%
EPS Next 3Y-6.23%

0

5. Dividend

5.1 Amount

No dividends for MGN!.
Industry RankSector Rank
Dividend Yield 0%

MAGNORA ASA

OSL:MGN (12/23/2025, 7:00:00 PM)

19.52

-0.32 (-1.61%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)10-24 2025-10-24/bmo
Earnings (Next)02-25 2026-02-25
Inst Owners17.28%
Inst Owner ChangeN/A
Ins Owners4.64%
Ins Owner ChangeN/A
Market Cap1.28B
Revenue(TTM)2.30M
Net Income(TTM)593.60M
Analysts86.67
Price Target36.04 (84.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend4.62
Dividend Growth(5Y)0.46%
DP8.1%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-210.19%
Min EPS beat(2)-312.69%
Max EPS beat(2)-107.69%
EPS beat(4)1
Avg EPS beat(4)227.83%
Min EPS beat(4)-312.69%
Max EPS beat(4)1409.9%
EPS beat(8)2
Avg EPS beat(8)56.72%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-86.23%
Min Revenue beat(2)-99.77%
Max Revenue beat(2)-72.69%
Revenue beat(4)2
Avg Revenue beat(4)-9.36%
Min Revenue beat(4)-99.77%
Max Revenue beat(4)118.97%
Revenue beat(8)5
Avg Revenue beat(8)19.58%
Revenue beat(12)7
Avg Revenue beat(12)171.94%
Revenue beat(16)8
Avg Revenue beat(16)117.36%
PT rev (1m)0%
PT rev (3m)-5.36%
EPS NQ rev (1m)36.23%
EPS NQ rev (3m)36.23%
EPS NY rev (1m)-57.55%
EPS NY rev (3m)-57.8%
Revenue NQ rev (1m)42.38%
Revenue NQ rev (3m)42.38%
Revenue NY rev (1m)-25.16%
Revenue NY rev (3m)-25.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.69
P/S 558.27
P/FCF N/A
P/OCF N/A
P/B 3.52
P/tB 5.95
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)3.43
Fwd EY17.57%
FCF(TTM)-1.64
FCFYN/A
OCF(TTM)-1.64
OCFYN/A
SpS0.03
BVpS5.54
TBVpS3.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 127.08%
ROE 162.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 25808.7%
GM N/A
FCFM N/A
ROA(3y)45.75%
ROA(5y)25.52%
ROE(3y)62.41%
ROE(5y)34.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y250.83%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.99
Altman-Z 7.69
F-Score4
WACC8.57%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)19.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-104.27%
EPS 3YN/A
EPS 5Y87.45%
EPS Q2Q%-106.44%
EPS Next Y-65.77%
EPS Next 2Y-9.51%
EPS Next 3Y-6.23%
EPS Next 5YN/A
Revenue 1Y (TTM)-80.99%
Revenue growth 3Y-46.71%
Revenue growth 5Y-43.96%
Sales Q2Q%-99.81%
Revenue Next Year-31.96%
Revenue Next 2Y1.38%
Revenue Next 3Y-3.11%
Revenue Next 5YN/A
EBIT growth 1Y75.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-47.84%
EBIT Next 3Y-6.04%
EBIT Next 5YN/A
FCF growth 1Y-820.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4795.45%
OCF growth 3YN/A
OCF growth 5YN/A

MAGNORA ASA / MGN.OL FAQ

What is the ChartMill fundamental rating of MAGNORA ASA (MGN.OL) stock?

ChartMill assigns a fundamental rating of 4 / 10 to MGN.OL.


Can you provide the valuation status for MAGNORA ASA?

ChartMill assigns a valuation rating of 2 / 10 to MAGNORA ASA (MGN.OL). This can be considered as Overvalued.


How profitable is MAGNORA ASA (MGN.OL) stock?

MAGNORA ASA (MGN.OL) has a profitability rating of 4 / 10.


What is the financial health of MAGNORA ASA (MGN.OL) stock?

The financial health rating of MAGNORA ASA (MGN.OL) is 7 / 10.


What is the expected EPS growth for MAGNORA ASA (MGN.OL) stock?

The Earnings per Share (EPS) of MAGNORA ASA (MGN.OL) is expected to decline by -65.77% in the next year.